1
Participants
Start Date
December 15, 2022
Primary Completion Date
September 30, 2024
Study Completion Date
December 31, 2024
Aliquoted allogeneic donor plasma in patient's conjunctiva
1-2 drops of allogenic aliquoted plasma to affected eye every 1-5 hours per day based on disease severity to be weaned down based on clinical response Administration period: Two to Six months. This may be repeated based on recurrence/worsening of conjunctivitis
RECRUITING
University of Saskatchewan, Saskatoon
Canadian Blood Services
OTHER
University of Saskatchewan
OTHER